SCHEMBL23108441

SCHEMBL23108441

c1cc(-c2ccc(-n3c4ccccc4c4cc(-c5nc6ccccc6o5)ccc43)cc2)cc(-c2ccc(-n3c4ccccc4c4cc(-c5nc6ccccc6o5)ccc43)cc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 10/20 0.47
▸ SMN1; SMN2 Q16637 7/20 0.47
▸ ALDH1A1 P00352 7/20 0.47
▸ HSD17B10 Q99714 7/20 0.47
▸ HPGD P15428 6/20 0.47
▸ TP53 P04637 6/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ PKM P14618 1/20 0.47
▸ NPC1 O15118 8/20 0.46
▸ RAB9A P51151 6/20 0.46
▸ MAPT P10636 4/20 0.46
▸ HCRTR1 O43613 2/20 0.46
▸ USP2 O75604 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ SENP8 Q96LD8 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23108467 1.00 KDM4E (0.47) KDM4ESMN1; SMN2ALDH1A1HSD17B10HPGD
SCHEMBL10065288 0.97 NPC1 (0.46) KDM4ESMN1; SMN2ALDH1A1HSD17B10HPGD
SCHEMBL10065179 0.97 NPC1 (0.46) KDM4ESMN1; SMN2ALDH1A1HSD17B10HPGD
SCHEMBL27282344 0.96 NPC1 (0.46) KDM4ESMN1; SMN2ALDH1A1HSD17B10HPGD
SCHEMBL22747043 0.95 KDM4E (0.51) KDM4ESMN1; SMN2ALDH1A1HSD17B10HPGD
SCHEMBL23108466 0.95 KDM4E (0.51) KDM4ESMN1; SMN2ALDH1A1HSD17B10HPGD
SCHEMBL10065318 0.95 NPC1 (0.47) KDM4ESMN1; SMN2ALDH1A1HSD17B10HPGD
SCHEMBL23097242 0.95 KDM4E (0.49) KDM4ESMN1; SMN2ALDH1A1HSD17B10HPGD
SCHEMBL22747045 0.95 KDM4E (0.49) KDM4ESMN1; SMN2ALDH1A1HSD17B10HPGD
SCHEMBL23097254 0.95 KDM4E (0.49) KDM4ESMN1; SMN2ALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3792259-B1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME CHANGCHUN HYPERIONS TECH CO LTD (CN) 2023-11-29 — — EP disclosed
US-20210078989-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME CHANGCHUN HYPERIONS TECHNOLOGY CO., LTD (CN) 2021-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078989-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME SOX18, TYR, L1CAM KDM4E 148/4885SMN1; SMN2 2991/4885ALDH1A1 1610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback